Survival and predictors of disability in Turkish MS patients

被引:140
作者
Kantarci, O
Siva, A
Eraksoy, M
Karabudak, R
Sütlas, N
Agaoglu, J
Turan, F
Özmenoglu, M
Togrul, E
Demirkiran, M
机构
[1] Istanbul Univ, Cerrahpasa Med Sch, Dept Neurol, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey
[3] Hacettepe Univ, Sch Med, Dept Neurol, Ankara, Turkey
[4] Bakirkoy State Hosp Mental & Neurol Illnesses, Dept Neurol, Istanbul, Turkey
[5] Okmeydam Social Secur Hosp, Dept Neurol, Istanbul, Turkey
[6] Uludag Univ, Sch Med, Dept Neurol, Bursa, Turkey
[7] Karadeniz Tech Univ, Sch Med, Dept Neurol, Trabzon, Turkey
[8] Gulhane Mil Med Acad, Dept Neurol, Istanbul, Turkey
[9] Cukurova Univ, Sch Med, Dept Neurol, Adana, Turkey
关键词
D O I
10.1212/WNL.51.3.765
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine the natural history, survival, and prognostic factors in a sample of Turkish MS patients. Method: This multicenter study included 1,259 definite MS patients diagnosed according to the criteria of Poser et al. Actuarial analysis of selected disability levels of 3, 6, 8, and 10 achieved with the Expanded Disability Status Scale (EDSS); a multivariate Cox regression analysis for prognostic factors related to time to reach EDSS greater than or equal to 6; and Pearson's correlation coefficient for individual factors were performed. Results: The survival (+/- SE) at 15 years from onset was 94.6 +/- 2.9%, and at 25 years was 89.0 +/- 5.8%. The disability reached by 15 years was EDSS greater than or equal to 3 in 66.4%, EDSS greater than or equal to 6 in 41.2%, EDSS greater than or equal to 8 in 10.5%, and EDSS = 10 in 5.4%. The most significant unfavorable prognostic factors were progressive course (relative risk [RR], 3.73; CI, 2.71 to 5.13) and sphincter symptoms at onset (RR, 1.86; CI, 1.23 to 2.82), followed by male sex, motor symptoms at onset, and a high attack frequency within the first 5 years. Primary progressive disease was correlated positively with male sex (r = 0.0895, p = 0.001), older age (I = 0.1807, p = 0.000), and motor (r = 0.1433, p = 0.000) or sphincter symptoms (r = 0.1001, p = 0.000) at onset, unlike relapsing-remitting and secondary progressive disease. Conclusions: Although a slightly better prognosis is observed in the Turkish MS population, early prognostic factors are similar to most of the previous Western series. Primary progressive disease, mostly seen in older men with motor and sphincter involvement at onset, has a worse prognosis and may represent a distinct behavioral variant of MS.
引用
收藏
页码:765 / 772
页数:8
相关论文
共 34 条
  • [1] FACTORS ASSOCIATED WITH A MALIGNANT OR BENIGN COURSE OF MULTIPLE-SCLEROSIS
    CLARK, VA
    DETELS, R
    VISSCHER, BR
    VALDIVIEZO, NL
    MALMGREN, RM
    DUDLEY, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (07): : 856 - 860
  • [2] COURSE AND PROGNOSIS OF MULTIPLE-SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA-PROCESSING OF 349 PATIENTS
    CONFAVREUX, C
    AIMARD, G
    DEVIC, M
    [J]. BRAIN, 1980, 103 (JUN) : 281 - 300
  • [3] COX DR, 1972, J R STAT SOC B, V34, P187
  • [4] FACTORS ASSOCIATED WITH A RAPID COURSE OF MULTIPLE-SCLEROSIS
    DETELS, R
    CLARK, VA
    VALDIVIEZO, NL
    VISSCHER, BR
    MALMGREN, RM
    DUDLEY, JP
    [J]. ARCHIVES OF NEUROLOGY, 1982, 39 (06) : 337 - 341
  • [5] LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS
    GOODKIN, DE
    RUDICK, RA
    MEDENDORP, SV
    DAUGHTRY, MM
    SCHWETZ, KM
    FISCHER, J
    VANDYKE, C
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (01) : 30 - 40
  • [6] HUGHES RAC, 1988, LANCET, V2, P179
  • [7] STUDIES ON NATURAL-HISTORY OF MULTIPLE-SCLEROSIS .8. EARLY PROGNOSTIC FEATURES OF LATER COURSE OF ILLNESS
    KURTZKE, JF
    BEEBE, GW
    NAGLER, B
    KURLAND, LT
    AUTH, TL
    [J]. JOURNAL OF CHRONIC DISEASES, 1977, 30 (12): : 819 - 830
  • [8] THE DISABILITY STATUS SCALE FOR MULTIPLE-SCLEROSIS - APOLOGIA PRO DSS SUA
    KURTZKE, JF
    [J]. NEUROLOGY, 1989, 39 (02) : 291 - 302
  • [9] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
  • [10] CLINICAL FACTORS ASSOCIATED WITH INCREASED DISABILITY IN MULTIPLE SCLEROSIS
    LEIBOWITZ, U
    ALTER, M
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1970, 46 (01): : 53 - +